How do you choose between moderate hypofractionation vs SBRT for intact low or intermediate risk prostate cancer patients?

In low-risk prostate cancer patients, hypofractionated regimens have been proven to be equivalent to standard fractionation in randomized studies (e.g. RTOG 0415 - Lee et al., PMID 27044935). Mulitiple non-randomized studies have shown that SBRT appears to have comparable results to historical contr...